Clinical Trial Update: Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating mebeverine for daytime and nocturnal incontinence after orthotopic ileal neobladders; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Incontinence
• Incontinence Daytime Urinary
• Incontinence Nighttime Urinary

Drugs mentioned

• Mebeverine (mebeverine)

Snippet

Sponsor: Mansoura University | Conditions: Oncology, Incontinence | Phase 4 | Status: COMPLETED